Brii Biosciences
Biotechnology Research in United States
Overview
Brii Biosciences Limited (“Brii Bio”, stock code: 2137.HK) is a biotechnology company developing therapies to improve patients’ health by addressing high unmet medical needs with limited treatment options. The Company is advancing a broad pipeline of unique therapeutic candidates with lead programs against hepatitis B virus (HBV) infection.
Established in 2018 and led by a visionary and experienced leadership team, Brii Bio now has operations in both China and the United States. On July 13, 2021, the Company was officially listed on the Hong Kong Stock Exchange under the stock code 2137.HK.
EMPLOYEES
51-200 employees
FOUNDED
2018
HQ
Durham, North Carolina
TYPE
Public Company
Location
- Street
- 110 N Corcoran St
- City
- Durham
- Region
- North Carolina
- Postal code
- 27701
- Country
- United States
Email patterns
See email patterns for Brii Biosciences
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
briibio.com is the website of Brii Biosciences.
What is the industry of the company?
Brii Biosciences (briibio.com) is in the Biotechnology Research industry.
What products and services does the company offer?
Brii Biosciences (briibio.com) lists these specialties: Biotechnology.
When was the company founded?
Brii Biosciences (briibio.com) was founded in 2018.
How many employees does the company have?
Brii Biosciences (briibio.com) has 51-200 employees.
What is the company type?
The company type of Brii Biosciences (briibio.com) is Public Company.
Where is the company headquartered?
Brii Biosciences (briibio.com) is headquartered in Durham, North Carolina.
What is the address of the company?
The address of Brii Biosciences (briibio.com) is 110 N Corcoran St, Durham, North Carolina, 27701, United States.
What are the social media accounts of the company?
The social media account of Brii Biosciences (briibio.com) is LinkedIn.
Social media